• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病和非糖尿病人群中的幽门螺杆菌感染与胰岛素抵抗

Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population.

作者信息

Vafaeimanesh Jamshid, Parham Mahmoud, Seyyedmajidi Mohammadreza, Bagherzadeh Mohammad

机构信息

Clinical Research Development Center, Department of Internal Medicine, Qom University of Medical Sciences, Qom, Iran.

Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

ScientificWorldJournal. 2014;2014:391250. doi: 10.1155/2014/391250. Epub 2014 Oct 23.

DOI:10.1155/2014/391250
PMID:25405220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4227459/
Abstract

Helicobacter pylori (HP) is a common worldwide infection with known gastrointestinal and nongastrointestinal complications. One of the gastrointestinal side effects posed for this organism is its role in diabetes and increased insulin resistance. The aim of this study was to evaluate the association between HP and insulin resistance in type 2 diabetic patients and nondiabetics. This cross-sectional study was carried out from May to December 2013 on 211 diabetic patients referred to diabetes clinic of Shahid Beheshti Hospital of Qom and 218 patients without diabetes. HP was evaluated using serology method and insulin resistance was calculated using HOMA-IR. The prevalence of H. pylori infection was 55.8% and 44.2% in diabetics and nondiabetics (P = 0.001). The study population was divided into two HP positive and negative groups. Among nondiabetics, insulin resistance degree was 3.01 ± 2.12 and 2.74 ± 2.18 in HP+ and HP- patients, respectively (P = 0.704). Oppositely, insulin resistance was significantly higher in diabetic HP+ patients rather than seronegative ones (4.484 ± 2.781 versus 3.160 ± 2.327, P = 0.013). In diabetic patients, in addition to higher prevalence of HP, it causes a higher degree of insulin resistance.

摘要

幽门螺杆菌(HP)是一种全球常见的感染菌,会引发已知的胃肠道及非胃肠道并发症。该病菌造成的一种胃肠道副作用是其在糖尿病及胰岛素抵抗增加方面所起的作用。本研究的目的是评估2型糖尿病患者和非糖尿病患者中幽门螺杆菌与胰岛素抵抗之间的关联。这项横断面研究于2013年5月至12月进行,研究对象为211名转诊至库姆市沙希德·贝赫什提医院糖尿病门诊的糖尿病患者以及218名非糖尿病患者。采用血清学方法评估幽门螺杆菌,使用稳态模型评估法(HOMA-IR)计算胰岛素抵抗。糖尿病患者和非糖尿病患者中幽门螺杆菌感染率分别为55.8%和44.2%(P = 0.001)。研究人群被分为幽门螺杆菌阳性和阴性两组。在非糖尿病患者中,幽门螺杆菌阳性和阴性患者的胰岛素抵抗程度分别为3.01±2.12和2.74±2.18(P = 0.704)。相反,糖尿病幽门螺杆菌阳性患者的胰岛素抵抗显著高于血清阴性患者(4.484±2.781对3.160±2.327,P = 0.013)。在糖尿病患者中,除了幽门螺杆菌感染率较高外,它还会导致更高程度的胰岛素抵抗。

相似文献

1
Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population.糖尿病和非糖尿病人群中的幽门螺杆菌感染与胰岛素抵抗
ScientificWorldJournal. 2014;2014:391250. doi: 10.1155/2014/391250. Epub 2014 Oct 23.
2
Diabetic patients infected with helicobacter pylori have a higher Insulin Resistance Degree.感染幽门螺杆菌的糖尿病患者胰岛素抵抗程度更高。
Caspian J Intern Med. 2014 Summer;5(3):137-42.
3
Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects.严重肥胖者的胃幽门螺杆菌感染与不良代谢特征相关。
Obesity (Silver Spring). 2013 Mar;21(3):535-7. doi: 10.1002/oby.20098.
4
Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?幽门螺杆菌感染率:糖尿病患者与非糖尿病患者是否存在差异?
Indian J Endocrinol Metab. 2015 May-Jun;19(3):364-8. doi: 10.4103/2230-8210.152773.
5
Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance.维生素D缺乏的糖尿病前期患者发生胰岛素抵抗的风险更高。
Clin Lab. 2019 May 1;65(5). doi: 10.7754/Clin.Lab.2018.181014.
6
Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications.有消化不良症状的糖尿病患者中幽门螺杆菌的患病率及其与血糖控制和晚期并发症的关系。
Dig Dis Sci. 2008 Oct;53(10):2646-9. doi: 10.1007/s10620-007-0185-7. Epub 2008 Mar 5.
7
Association between non-insulin-based insulin resistance surrogate makers and Helicobacter pylori infection: a population-based study.非胰岛素类胰岛素抵抗替代指标与幽门螺杆菌感染之间的关联:一项基于人群的研究。
BMC Gastroenterol. 2025 Jan 21;25(1):25. doi: 10.1186/s12876-025-03610-x.
8
Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference?幽门螺杆菌感染与否的糖尿病患者血清脂联素水平:有差异吗?
ScientificWorldJournal. 2014 Jan 9;2014:402685. doi: 10.1155/2014/402685. eCollection 2014.
9
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.一项随机、双盲、安慰剂对照试验,旨在评估根除幽门螺杆菌对2型糖尿病患者葡萄糖稳态的影响。
Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):893-8. doi: 10.1016/j.numecd.2016.06.012. Epub 2016 Jul 1.
10
[Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients].[幽门螺杆菌对2型糖尿病患者血糖波动的影响]
Zhonghua Yi Xue Za Zhi. 2009 Apr 14;89(14):958-61.

引用本文的文献

1
infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes.感染与慢性病的关联:聚焦心血管疾病、代谢功能障碍相关脂肪性肝病和2型糖尿病。
Metabol Open. 2025 Aug 11;27:100385. doi: 10.1016/j.metop.2025.100385. eCollection 2025 Sep.
2
A Comprehensive Survey of the Relationship between Infection and Atherosclerosis in the Iranian Population: A Systematic Review and Meta-analysis.伊朗人群中感染与动脉粥样硬化关系的全面调查:系统评价和荟萃分析。
Arch Iran Med. 2022 Apr 1;25(4):257-266. doi: 10.34172/aim.2022.42.
3
Association of Helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance: an updated systematic review and meta-analysis.幽门螺杆菌感染与代谢综合征及胰岛素抵抗风险的关联:一项更新的系统评价与荟萃分析
Diabetol Metab Syndr. 2021 Dec 18;13(1):145. doi: 10.1186/s13098-021-00765-x.
4
Immunological Mechanisms of Sickness Behavior in Viral Infection.病毒感染中的疾病行为的免疫机制。
Viruses. 2021 Nov 8;13(11):2245. doi: 10.3390/v13112245.
5
The impact of infection on gut microbiota-endocrine system axis; modulation of metabolic hormone levels and energy homeostasis.感染对肠道微生物群-内分泌系统轴的影响;代谢激素水平的调节和能量稳态。
J Diabetes Metab Disord. 2020 Aug 11;19(2):1855-1861. doi: 10.1007/s40200-020-00608-y. eCollection 2020 Dec.
6
Type 2 diabetes and viral infection; cause and effect of disease.2 型糖尿病与病毒感染;疾病的因果关系。
Diabetes Res Clin Pract. 2021 Feb;172:108637. doi: 10.1016/j.diabres.2020.108637. Epub 2021 Jan 13.
7
Prevalence of Infection among Type 2 Diabetes Mellitus.2型糖尿病患者中的感染患病率。
Adv Biomed Res. 2020 Jul 27;9:27. doi: 10.4103/abr.abr_248_19. eCollection 2020.
8
First-line eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus.2型糖尿病患者的一线根除率显著低于非2型糖尿病患者。
Infect Drug Resist. 2019 May 29;12:1425-1431. doi: 10.2147/IDR.S194584. eCollection 2019.
9
eradication in patients with type 2 diabetes mellitus: Multicenter prospective observational study.2型糖尿病患者的根除:多中心前瞻性观察性研究。
SAGE Open Med. 2019 Feb 19;7:2050312119832093. doi: 10.1177/2050312119832093. eCollection 2019.
10
Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis.感染与 2 型糖尿病患者蛋白尿的发生相关:系统评价和荟萃分析。
Chin Med J (Engl). 2018 Nov 20;131(22):2734-2740. doi: 10.4103/0366-6999.245269.

本文引用的文献

1
The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance.幽门螺杆菌血清阳性在胰岛素敏感性、β细胞功能及糖耐量异常中的作用
Scientifica (Cairo). 2014;2014:870165. doi: 10.1155/2014/870165. Epub 2014 Mar 25.
2
Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?幽门螺杆菌感染与冠状动脉疾病的关联:幽门螺杆菌是一个危险因素吗?
ScientificWorldJournal. 2014 Jan 16;2014:516354. doi: 10.1155/2014/516354. eCollection 2014.
3
Helicobacter pylori seropositivity in patients with type 2 diabetes mellitus in south-east of Iran.伊朗东南部2型糖尿病患者的幽门螺杆菌血清阳性情况。
Acta Med Iran. 2013;51(12):892-6.
4
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90. doi: 10.2337/dc14-S081.
5
Helicobacter pylori infection as a cause of iron deficiency anaemia of unknown origin.幽门螺杆菌感染作为不明原因缺铁性贫血的病因。
World J Gastroenterol. 2013 Jul 14;19(26):4166-71. doi: 10.3748/wjg.v19.i26.4166.
6
Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies.幽门螺杆菌感染与糖尿病的关系:观察性研究的荟萃分析。
Diabetes Res Clin Pract. 2013 Feb;99(2):200-8. doi: 10.1016/j.diabres.2012.11.012. Epub 2013 Feb 8.
7
High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study.年轻 1 型糖尿病患者幽门螺杆菌再感染率高:一项为期 3 年的随访研究。
Eur Rev Med Pharmacol Sci. 2012 Oct;16(11):1468-72.
8
Platelet Count Response to Helicobacter pylori Eradication in Iranian Patients with Idiopathic Thrombocytopenic Purpura.伊朗特发性血小板减少性紫癜患者幽门螺杆菌根除后血小板计数反应。
Mediterr J Hematol Infect Dis. 2012;4(1):e2012056. doi: 10.4084/MJHID.2012.056. Epub 2012 Aug 10.
9
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.幽门螺杆菌感染与非酒精性脂肪性肝病。
Metabolism. 2013 Jan;62(1):121-6. doi: 10.1016/j.metabol.2012.06.007. Epub 2012 Jul 27.
10
Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia.糖尿病和非糖尿病消化不良患者中的幽门螺杆菌
Acta Med Iran. 2012;50(5):315-8.